Studies in animal models have shown that insulin resistance and impaired insulin signaling exacerbate neurodegenerative processes in Alzheimer’s disease by affecting amyloid-beta accumulation and neuronal deficits [19, 20]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.